Merck & Co. Inc. (MRK) | Income Statement
See also
- Johnson & Johnson (JNJ), Income Statement
- Pfizer Inc. (PFE), Income Statement
- Novartis AG (NVS), Income Statement
- GlaxoSmithKline PLC (GSK), Income Statement
- Abbott Laboratories (ABT), Income Statement
- Sanofi (SNY), Income Statement
- Novo Nordisk A/S (NVO), Income Statement
- UnitedHealth Group Inc. (UNH), Income Statement
- Bristol-Myers Squibb Co. (BMY), Income Statement
- AstraZeneca PLC (AZN), Income Statement
- Eli Lilly & Co. (LLY), Income Statement
- Medtronic Inc. (MDT), Income Statement
- Baxter International Inc. (BAX), Income Statement
ˇ Show More
The income statement presents information on the financial results of a company's business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Merck & Co. Inc., Consolidated Income Statement
USD $ in millions
| 12 months ended | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|---|---|
 |
Sales | |
|
|
|
|
|
Materials and production | |
|
|
|
|
|
Marketing and administrative | |
|
|
|
|
|
Research and development | |
|
|
|
|
|
Restructuring costs | |
|
|
|
|
|
U.S. Vioxx Settlement Agreement charge | |
|
|
|
|
|
Operating income | |
|
|
|
|
|
Equity income from affiliates | |
|
|
|
|
|
Interest income | |
|
|
|
|
|
Interest expense | |
|
|
|
|
|
Exchange gains (losses) | |
|
|
|
|
|
Other, net | |
|
|
|
|
|
Other income (expense), net | |
|
|
|
|
|
Income before taxes | |
|
|
|
|
|
Taxes on income | |
|
|
|
|
|
Net income | |
|
|
|
|
|
Net income attributable to noncontrolling interests | |
|
|
|
|
|
Net income attributable to Merck & Co., Inc. | |
|
|
|
|
| Item | Description | The company |
|---|---|---|
| Sales | Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. | Merck & Co. Inc.'s sales increased from 2009 to 2010 and from 2010 to 2011. |
| Operating income | The net result for the period of deducting operating expenses from operating revenues. | Merck & Co. Inc.'s operating income declined from 2009 to 2010 but then increased from 2010 to 2011 exceeding 2009 level. |
| Income before taxes | Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. | Merck & Co. Inc.'s income before taxes declined from 2009 to 2010 but then slightly increased from 2010 to 2011. |
| Net income | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | Merck & Co. Inc.'s net income declined from 2009 to 2010 but then slightly increased from 2010 to 2011. |
| Net income attributable to Merck & Co., Inc. | The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. | Merck & Co. Inc.'s net income attributable to Merck & Co., Inc. declined from 2009 to 2010 but then slightly increased from 2010 to 2011. |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center